InvestorsHub Logo
Followers 19
Posts 628
Boards Moderated 0
Alias Born 04/17/2013

Re: rafunrafun post# 115483

Wednesday, 10/04/2017 6:52:10 PM

Wednesday, October 04, 2017 6:52:10 PM

Post# of 425648
Raf,

Vascepa was safer than an aspirin..... the FDA could have put a condition of approval to maintain the SPA to protect the consumer if any side effects were to occurr.... thus the SPA contract could have been maintained....
The FDA so stated that a conditional approval would be hard to rescind...thats "BULL"... the FDA almost bankrupted Amarin and in doing so would have possibly kept one new drug from coming to the market...a drug that hints of various outstanding results.

The FDA was manipulated by internal and external forces to keep Vascepa from coming to the market...the ADCOM was a setup to rescind the SPA... I have been in the market for 40 years and AMARIN'S survival is a miracle...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News